A Major Milestone for HealthEconomics.Com: A Letter from Dr. Peeples to Our Readers
Few health economists have the mission to create a globally recognized website of highly curated resources for health economics and outcomes research. Neither did I. But, as the unattributed English proverb states, "Necessity is the mother of invention".
Aetion, HealthVerity Launch RWE System
Aetion and HealthVerity last month launched a new real-world evidence system aimed at helping the assessment of treatment approaches for [...]
PRMA Offers Tips on Working From Home
PRMA Consulting in a recent blog post offers six key tips for bolstering connectivity and productivity while working from home. [...]
Blog: What do High Drug Prices Buy Us?
A recent Health Affairs blog post looks at what the U.S. is actually getting with such high drug prices. The [...]
Can Medtech Use Social Media to Generate RWE?
GP and digital RWE advisor Simon Rudland and Orbital Research CEO Peter Brady in a recent interview with Med-Tech Innovation [...]
ISPOR Launches COVID-19 News Service
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has launched a new, COVID-19-focused service to supplement its main site. [...]
A Look at Cummings’ Drug Pricing Law
While the Elijah Cummings Lower Drug Costs Now Act would reduce drug prices, The Commonwealth Fund says the impact on [...]
Preparing for a COVID-19 Vaccine
A recent Health Affairs blog post considers the challenges that lie ahead of a potential COVID-19 vaccine. The rollout of [...]
COVID-19 Evidence Accelerator Aims to Facilitate Collaboration
The Reagan-Udall Foundation, in partnership with Friends of Cancer Research, recently launched a new initiative for the FDA aimed at [...]
ICER Taps Campbell as Senior VP for Health Economics
The Institute for Clinical and Economic Review (ICER) on Thursday, April 23, announced the appointment of Jonathan Campbell as the [...]
JCPH’s Nash Discusses Return to Normalcy After First Wave of COVID-19
Jefferson College of Public Health Founding Dean Emeritus David Nash says testing will be key as the U.S. looks to [...]
Report: Remdesivir Trials Posting Promising Results
Gilead's COVID-19 treatment, remdesivir, is showing some promise in clinical trials which have seen swift recoveries of symptoms in severe [...]
Frakt, Stevens Seek Input on Planned Survey on Post-Pandemic Predictions
Rob Stevens and Austin Frakt are developing a survey on predictions for post-pandemic behavior and trends, and have asked for [...]
NHC Launches Online Value Classroom
The National Health Council (NHC) recently announced the launch of the Value Classroom, a new online learning platform aimed at [...]
HealthCore’s Beachler, Lanes Talk Bolstering RWE with New Tech
In the latest tHEORetically Speaking blog post, HealthCore's Daniel Beachler, Safety & Epidemiology associate director, and Stephen Lanes, Safety & [...]
ICER Names Venable VP of Patient Engagement
The Institute for Clinical and Economic Review (ICER) announced the appointment of Yvette Venable as its first-ever vice president of [...]
Health Care Industry Leveraging RWD to Combat COVID-19
The health care industry is looking to better leverage real-world data in the midst of the COVID-19 pandemic as it [...]
Program Looks to Address Gaps in COVID-19 Data
The Robert Wood Johnson Foundation's Health Data for Action program is supporting a collaboration between Health Care Cost Institute (HCCI), [...]
Clayton-Welch: Quality, Speed, Compliance Key in Dynamic Market Access Landscape
In the second of her five-part series on digital transformation in market access, HealthEconomics.Com© LLC CEO Patti Peeples sits down [...]
Prime Therapeutics Initiative Aims to Help Plan Sponsors Pay for Gene Therapies
The new PreserveRx program from Prime Therapeutics looks to help plan sponsors deal with high-cost gene therapies, Fierce Healthcare reports. [...]
The things you need to know about the digital transformation of primary research
In the rapidly evolving market access landscape, it’s important to quickly identify current payer perspectives to determine future trends. High-quality, rapid primary research can be key to fast-forwarding your strategy.
HealthEconomics.Com, Scientist.Com Announce HEOR, RWE Partnership
HealthEconomics.Com© LLC and Scientist.Com are partnering to streamline HEOR and real-world evidence sourcing in the global HEOR and RWE community [...]
Blog Post Highlights Impact Coronavirus Could Have on New Drug Launches
A recent blog post on Tribeca Knowledge outlines some of the key challenges pharmaceutical companies face regarding drug launches in [...]
Shkreli Seeks Furlough to Research Potential COVID-19 Treatments
Disgraced biotech entrepreneur Martin Shkreli is requesting a 3-month furlough to research potential treatments for COVID-19, STAT reports. In a [...]
ISPOR 2020 Goes Virtual
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is moving its annual meeting into the virtual space in response [...]